---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012962"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-09-10T23:59:59+00:00"
generated_at: "2026-05-17T07:04:22.827738+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics prices $25M public offering of 25M shares at $1.00 per share

## Summary
- Priced 25,000,000 shares of common stock at $1.00 per share; gross proceeds ~$25M before expenses.
- Underwriters granted 30-day option to purchase up to additional 3,750,000 shares at the same price.
- Net proceeds to be used for working capital and general corporate purposes; closing expected Sept 11, 2025.
- Canaccord Genuity and BTIG are joint bookrunners; Maxim Group is co-manager.
- Offering made under effective shelf registration statement S-3 (No. 333-268560).

## SEC filing metadata
- accession: 0001493152-25-012962
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-09-10T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315225012962/0001493152-25-012962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315225012962/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012962
- JSON: https://secwatch.observer/filing/0001493152-25-012962.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012962.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.